Core Insights - The China Securities Regulatory Commission (CSRC) has requested additional information from Kefu Medical regarding its overseas listing application, specifically concerning its domestic subsidiaries and compliance with regulations [1] - Kefu Medical is one of the largest home medical device companies in China, ranking second in sales among all home medical device enterprises according to Frost & Sullivan [2] - The company has expanded its global presence, covering over 60 countries and regions across Asia, Africa, Europe, and America, attracting a growing loyal customer base [2] Group 1 - The CSRC requires Kefu Medical to clarify whether its domestic subsidiaries fall under the prohibitions outlined in the "Interim Measures for the Administration of Overseas Issuance and Listing of Domestic Enterprises" [1] - Kefu Medical operates 738 self-owned stores in China, with 689 being "Jianer Hearing" service centers, covering over 135 cities [2] - The "Jianer Hearing" service centers provide professional hearing testing services and supply various high-quality hearing aid products, including Kefu's own brand [2] Group 2 - The CSRC has asked Kefu Medical to provide details on its subsidiaries' business scope, including advertising services, and whether they have obtained the necessary licenses [1] - Kefu Medical's "Jianer Hearing" ranks among the top three in the industry based on the number of hearing aid fitting centers in China as of the end of 2024 [2] - The company is also required to explain its compliance with foreign investment restrictions as outlined in the "Negative List for Foreign Investment Access (2024 Edition)" [1]
新股消息 | 可孚医疗拟港股IPO 中国证监会要求说明境内子公司是否存在相关规定的不得境外发行上市情形